排序方式: 共有11条查询结果,搜索用时 15 毫秒
1.
静脉炎是静脉输液后引起的静脉局部疼痛、红肿、水肿或局部条索状,甚至出现硬结的炎性改变,是静脉输液中最常见的并发症.美国静脉输液学会颁布的指南中认为,可接受的外周静脉输液性静脉炎的发生率为5%,一些调查甚至显示接收静脉注射的患者中有80%存在程度不同的静脉炎[1]. 相似文献
2.
3.
Objectives:To observe the clinical effect on opioid-induced constipation of liver stagnation and spleen deficiency treated with the ultrasonic penetration of the No.1 constipation herbal formula at Tiānshū(天枢 ST25).Methods:A total of 126 patients that were in compliance with the inclusion criteria were randomized into an acupoint group(41 cases),a Chinese medication group(42 cases) and a western medication group(43 cases).In the acupoint group,the ultrasonic penetration of the No.1 constipation ... 相似文献
4.
5.
2001年6月~2003年7月,我们施行腹腔镜胆囊切除术(laparoscopic cholecystectomy,LC)156例,无一例中转开腹,无严重并发症发生,术后病人恢复良好,疗效满意,现报道如下. 相似文献
6.
我们 2000年 2月~ 2003年 11月采用本院院内制剂参麦冻干粉针治疗心绞痛及心律失常 48例,疗效较佳.现报告如下. 相似文献
7.
ObjectivesTo observe the clinical effect on opioid-induced constipation of liver stagnation and spleen deficiency treated with the ultrasonic penetration of the No.1 constipation herbal formula at Tiānshū (天枢 ST25).MethodsA total of 126 patients that were in compliance with the inclusion criteria were randomized into an acupoint group (41 cases), a Chinese medication group (42 cases) and a western medication group (43 cases). In the acupoint group, the ultrasonic penetration of the No.1 constipation herbal formula at bilateral Tiānshū (天枢 ST25) were given. In the Chinese herbal medication group, the No.1 constipation herbal formula was prescribed for oral administration. In the western medication group, polyethylene glycol electrolyte powder was prescribed for oral administration. The treatment was given once a day, for 14 days totally. Before and after treatment, the constipation symptom score, the score of the patient assessment of constipation quality of life (PAC-QOL), the situation of nitric oxide synthetase (NOS) in serum were observed in each group. The safety indicators in the observation included diarrhea, allergic reaction, liver dysfunction, skin lesions, etc.ResultsA total of 122 cases accomplished the trial. The total effective rate was 82.5% in the acupoint group, 80.48% in the Chinese medication group and 78.04% in the western medication group. The constipation symptoms were all relieved in the three groups, indicating the statistical significance as compared with those before treatment (P < 0.01, P < 0.05). In the acupoint group and the western medication group, the improvements in the three symptom items, i.e. distention or scurrying pain in the chest, hypochondriac region or the bilateral sides of the abdomen, depression or irritability and poor appetite, were better than the western medication group (P < 0.01, P < 0.05). The improvements in all of the symptoms in the acupoint group were better than the Chinese medication group (all P < 0.05). The PAC-QOL score was improved in each group after treatment and it was different significantly in statistics as compared with that before treatment in each group. After treatment, the improvement of PAC-QOL score in the acupoint group and the Chinese medication group was better than that in the western medication group (both P < 0.05), and the improvement in the acupoint group was better than the Chinese medication group (P < 0.05). As to serum NOS, after treatment, it was different significantly as compared with that before treatment in each group (all P < 0.05), the improvement in the acupoint group was better than that of either the Chinese medication group or the western medication group, indicating the statistical significance (both P < 0.05). The incidence of adverse reaction in the acupoint group was less and different significantly as compared with the western medication group (P < 0.01), and it was different statistically as compared with the Chinese medication group (P < 0.05).ConclusionThe ultrasonic penetration of the No.1 constipation herbal formula at Tiānshū (天枢 ST25) is effective on opioid-induced constipation of liver stagnation and spleen deficiency. This therapy achieves the significant therapeutic effect and presents the good compliance in treatment. Hence, it deserves to be further promoted in clinical application. 相似文献
8.
9.
10.
安置胃管是护理许多危急重病患者经常需要采取的一项技能,如有机磷农药中毒的患者,为尽快清除胃内毒物,需要紧急安置胃管洗胃;急性胰腺炎等需要胃肠减压的患者,也常需要安置胃管;一些危重或神志不清的患者更需要安置胃管,以达到鼻饲供给营养、药物和能量等目的. 相似文献